Indication
Epidyolex is indicated for use as adjunctive therapy of seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome (DS), in conjunction with clobazam, for patients 2 years of age and older.
Loading your page…
Loading your page…
Lennox Gastaut Syndrome;Epilepsies, Myoclonic
Marketing Authorisation Holder: Jazz Pharmaceuticals Ireland Limited
EMA Authorisation: 19/09/2019
INN: cannabidiol
AI Drug & Interaction Analysis
Free account required
Ask Osler about Epidyolex: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.